AERMED'S CLOAK CONSULTING, INC. – Trademark Portfolio
Entity Type: 03
AERMED'S CLOAK CONSULTING, INC. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include J-PRO, TEAM ACL, and AERMED'S CLOAK. The owner is based in Phoenix, AZ.
1938 East Osborn Rd.
Phoenix, AZ 85016
Showing of trademarks Trademarks
Trademark Classifications
AERMED'S CLOAK CONSULTING, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does AERMED'S CLOAK CONSULTING, INC. have?
AERMED'S CLOAK CONSULTING, INC. has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does AERMED'S CLOAK CONSULTING, INC. file in?
AERMED'S CLOAK CONSULTING, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 25 (Clothing), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are AERMED'S CLOAK CONSULTING, INC.'s most well-known trademarks?
AERMED'S CLOAK CONSULTING, INC.'s registered trademark portfolio includes well-known marks such as J-PRO, TEAM ACL, and AERMED'S CLOAK. These are among 3 currently registered trademarks in the portfolio.
What is AERMED'S CLOAK CONSULTING, INC.'s trademark registration success rate?
AERMED'S CLOAK CONSULTING, INC. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.